Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Ascend Laboratories, LLC recalls Dabigatran Etexilate

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Products
  • Dabigatran Etexilate
Where it was sold

Nationwide within the United States

Nationwide

Units affected
10,444 bottles
About this recall
Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60